Align Technology, Inc. (ALGN) Stock Analysis
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
Align Technology, Inc. is a healthcare company focused on clear aligners; based on its strong growth prospects, brand dominance, and a DCF valuation suggesting a fair value above its current price, it appears undervalued.
Investment Recommendation
Buy
Fair Value: $365.78
Current Price: $280.55
Upside/Downside: +30.37%
The DCF analysis indicates an implied fair value per share significantly higher than the current market price, suggesting substantial upside potential. This is driven by Align Technology's projected strong revenue growth, improving margins, and its dominant position in the expanding clear aligner market.
Key Metrics
- Market Cap: $22.41B
- P/E Ratio: 40.25x
- Forward P/E: 25.13x
- Revenue Growth (YoY): 6.6%
- Net Margin: 15.6%
- ROE: 18.5%
- Debt/Equity: 0.01
- Dividend Yield: 0%
Strengths
- Dominant market share in the clear aligner segment with its Invisalign system.
- Strong brand recognition and customer loyalty.
- Continuous innovation in treatment planning and material science.
- Expanding global reach and penetration in emerging markets.
Risk Factors
- Increasing competition from both established players and new entrants.
- Potential for regulatory changes or shifts in reimbursement policies.
- Dependence on dental professionals for adoption and prescription of its products.
- Sensitivity to macroeconomic conditions affecting discretionary healthcare spending.